BE893193A - Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif - Google Patents

Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif

Info

Publication number
BE893193A
BE893193A BE0/208097A BE208097A BE893193A BE 893193 A BE893193 A BE 893193A BE 0/208097 A BE0/208097 A BE 0/208097A BE 208097 A BE208097 A BE 208097A BE 893193 A BE893193 A BE 893193A
Authority
BE
Belgium
Prior art keywords
cholecalciferol
dihydroxy
pharmaceutical composition
active ingredient
composition containing
Prior art date
Application number
BE0/208097A
Other languages
English (en)
Original Assignee
Kureha Chemical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP7326481A external-priority patent/JPS57188520A/ja
Priority claimed from JP19801581A external-priority patent/JPS58109422A/ja
Priority claimed from JP19801681A external-priority patent/JPS58109421A/ja
Priority claimed from JP1860082A external-priority patent/JPS58135812A/ja
Priority claimed from JP6286882A external-priority patent/JPS58185519A/ja
Priority claimed from JP6568982A external-priority patent/JPS58185520A/ja
Priority claimed from JP7068282A external-priority patent/JPS58188816A/ja
Application filed by Kureha Chemical Ind Co Ltd filed Critical Kureha Chemical Ind Co Ltd
Publication of BE893193A publication Critical patent/BE893193A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE0/208097A 1981-05-15 1982-05-14 Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif BE893193A (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP7326481A JPS57188520A (en) 1981-05-15 1981-05-15 Antihyperkalemia
JP19801581A JPS58109422A (ja) 1981-12-09 1981-12-09 抗潰瘍剤
JP19801681A JPS58109421A (ja) 1981-12-09 1981-12-09 免疫機能低下防止剤
JP1860082A JPS58135812A (ja) 1982-02-08 1982-02-08 マグネシウム代謝調節剤
JP6286882A JPS58185519A (ja) 1982-04-15 1982-04-15 抗高燐血症剤
JP6568982A JPS58185520A (ja) 1982-04-20 1982-04-20 血糖調節剤
JP7068282A JPS58188816A (ja) 1982-04-27 1982-04-27 抗腫瘍剤

Publications (1)

Publication Number Publication Date
BE893193A true BE893193A (fr) 1982-11-16

Family

ID=27563835

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/208097A BE893193A (fr) 1981-05-15 1982-05-14 Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif

Country Status (3)

Country Link
US (1) US4442093A (fr)
BE (1) BE893193A (fr)
IT (1) IT1190824B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1272953A (fr) * 1984-10-08 1990-08-21 Yuji Makino Compose pharmaceutique pour usage externe contenant de la vitasmine d.sub.3 de type acitf
JPH07100685B2 (ja) * 1985-08-02 1995-11-01 レオ・ファ−マシュ−ティカル・プロダクツ・リミテッド・エイ／エス（レ−ベンス・ケミスケ・ファブリック・プロデュクチオンスアクチ−セルスカブ） 新規ビタミンｄ類似体
IL77668A (en) * 1986-01-21 1989-03-31 Teva Pharma Production of cholecalciferol derivatives and novel intermediates used therefor
US4677075A (en) * 1986-05-05 1987-06-30 Louderback Allan Lee Urobilinogen control
JPS6391323A (ja) * 1986-10-03 1988-04-22 Kureha Chem Ind Co Ltd 抗尿路結石症剤
US5001118A (en) * 1986-12-29 1991-03-19 Kureha Kagaku Kogyo Kabushiki Kaisha Method for preventing senescence and increasing bone mass
US4997824A (en) * 1987-07-22 1991-03-05 Teva Pharmaceutical Industries Ltd. Combination of cholecalciferol derivatives for the treatment of renal bone disease
US5393742A (en) * 1990-08-30 1995-02-28 Mect Corporation Preparation for treating renal disease
US6291444B1 (en) * 1993-06-16 2001-09-18 Wisconsin Alumni Research Foundation Treatment of t-cell immunodeficiencies with vitamin D compounds
US7129230B2 (en) 2001-03-12 2006-10-31 Nestec S.A. Method and product for treating cancer in pets
ES2593047T3 (es) 2006-02-03 2016-12-05 Opko Renal, Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
ES2670029T3 (es) 2006-06-21 2018-05-29 Opko Ireland Global Holdings, Ltd. Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D
US11752158B2 (en) 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency
KR20190028822A (ko) 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
EP2182971B1 (fr) * 2007-07-27 2013-12-18 Humacyte, Inc. Compositions à base de collàgene et élastine et leurs utilisations
US20090048160A1 (en) * 2007-08-17 2009-02-19 Bannerman Douglas D Antimicrobial activity of bovine bactericidal/permeability-increasing protein (BPI)-derived peptides against Gram-negative bacterial mastitis isolates
AU2010249805B2 (en) * 2009-05-20 2015-06-11 Humacyte, Inc. Elastin for soft tissue augmentation
WO2011123476A1 (fr) 2010-03-29 2011-10-06 Cytochroma Inc. Procédés et compositions pour réduction de taux d'hormone parathyroïde
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
JP7032322B2 (ja) 2016-03-28 2022-03-08 オプコ アイルランド グローバル ホールディングス リミテッド ビタミンｄ治療法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3715374A (en) * 1972-05-05 1973-02-06 Wisconsin Alumni Res Found 24,25-dihydroxycholecalciferol
US3994878A (en) * 1975-10-10 1976-11-30 Hoffmann-La Roche Inc. Syntheses of 24R,25- and 24S,25-dihydroxycholesterol and alkanoyl derivatives thereof
JPS55136229A (en) * 1979-04-10 1980-10-23 Teijin Ltd Adjustment of bone metabolism in warm-blooded animal and drug for it

Also Published As

Publication number Publication date
US4442093A (en) 1984-04-10
IT8221278A0 (it) 1982-05-14
IT1190824B (it) 1988-02-24

Similar Documents

Publication Publication Date Title
BE893193A (fr) Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
FR2602141B1 (fr) Composition pharmaceutique a activite analgesique contenant de l'ibuprofene comme principe actif
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
FR2526271B1 (fr) Composition herbicide contenant un derive de 1, 2, 4-triazole a titre d'ingredient actif
FR2510888B1 (fr) Nouvelles compositions a usage pharmaceutique a effet prolonge de liberation d'un ingredient actif
FR2527597B1 (fr) Derives d'alcool b,g-dihydropolyprenylique et composition pharmaceutique contenant un compose polyprenylique
FR2569694B1 (fr) Derives d'ethylenediaminemonoamide, composition pharmaceutique les contenant et utilisation de ces composes a titre d'antidepresseur ou d'antiparkinsonien
FR2567510B1 (fr) Composes d'aminophenol et compositions pharmaceutiques les contenant
BE879472A (fr) Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines
FR2490491B1 (fr) Composition pharmaceutique analgesique contenant comme ingredient actif l'acide 3-amino-2-hydroxy-4 phenylbutanoique et ses derives et application
BE861888A (fr) Compositions contenant un derive de l'acide salicyclique et applications a titre de medicament
FR2515038B1 (fr) A titre de medicaments, certains derives de l'acide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant
FR2540498B1 (fr) Nouveaux medicaments derives d'amides d'acide mercaptoacetique et de l'acide 3-mercaptopropionique et les compositions pharmaceutiques les renfermant
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
FR2585953B1 (fr) Composition pharmaceutique pour l'administration orale contenant de l'ubiquinone et procede
IT1191651B (it) Composti acilamminoalcanoilici ad attivita' farmaceutica
FR2614788B1 (fr) Composition pharmaceutique a activite antiseptique
FR2505824B1 (fr) Derives d'isoprenylamine et leur application a des compositions pharmaceutiques
BE890011A (fr) Nouvelles compositions pharmaceutiques contenant de l'almitrine
FR2556592B1 (fr) Compositions pharmaceutiques contenant des derives de l'acide campho-methylidene cinnamique
BE892911A (fr) Nitroimidazoles a activite trichomonacide, leur preparation et compositions pharmaceutiques en contenant
FR2526432B1 (fr) Derive de tetrahydrobenzothiazole et composition herbicide contenant celui-ci, a titre d'ingredient actif
FR2607005B1 (fr) Compositions pharmaceutiques contenant de l'acide ursodesoxycholique
FR2483918B1 (fr) Composition anti-inflammatoire contenant a titre de principe actif des derives de l'acide phenyl-acetique ou phenyl-propionique

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: KUREHA KAGAKU KOGYO K.K.

Effective date: 19980531